179 related articles for article (PubMed ID: 35523034)
61. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.
Morgentaler A; Traish A; Hackett G; Jones TH; Ramasamy R
Sex Med Rev; 2019 Oct; 7(4):636-649. PubMed ID: 31351915
[TBL] [Abstract][Full Text] [Related]
62. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
[TBL] [Abstract][Full Text] [Related]
63. The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
Kopp RP; Marshall LM; Wang PY; Bauer DC; Barrett-Connor E; Parsons JK;
Eur Urol; 2013 Oct; 64(4):672-9. PubMed ID: 23587870
[TBL] [Abstract][Full Text] [Related]
64. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
[TBL] [Abstract][Full Text] [Related]
65. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
[TBL] [Abstract][Full Text] [Related]
66. The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.
Anderson-Carter I; Posielski N; Liou JI; Khemees TA; Downs TM; Abel EJ; Jarrard DF; Richards KA
Urol Oncol; 2019 Feb; 37(2):130-137. PubMed ID: 30528885
[TBL] [Abstract][Full Text] [Related]
67. Controversies with testosterone therapy.
Khera M
Can J Urol; 2020 Aug; 27(S3):20-23. PubMed ID: 32875998
[TBL] [Abstract][Full Text] [Related]
68. The causes and effects of socio-demographic exclusions from clinical trials.
Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
[TBL] [Abstract][Full Text] [Related]
69. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
[TBL] [Abstract][Full Text] [Related]
70. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
Nilsson G; Samuelsson E; Söderström L; Mooe T
BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
[TBL] [Abstract][Full Text] [Related]
71. Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden.
George G; Vikman H; Gedeborg R; Lissbrant IF; Garmo H; Styrke J; Van Hemelrijck M; Stattin P
Acta Oncol; 2021 Apr; 60(4):459-465. PubMed ID: 33606571
[TBL] [Abstract][Full Text] [Related]
72. Testosterone Therapy in Advanced Prostate Cancer.
Chedrawe E; Sathe A; White J; Ory J; Ramasamy R
Androg Clin Res Ther; 2022; 3(1):180-186. PubMed ID: 36684061
[TBL] [Abstract][Full Text] [Related]
73. The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta-analysis.
Yang H; Pang L; Hu X; Wang W; Xu B; Zhang X; Liu L
J Clin Pharm Ther; 2020 Jun; 45(3):488-495. PubMed ID: 31951037
[TBL] [Abstract][Full Text] [Related]
74. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
75. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
[TBL] [Abstract][Full Text] [Related]
76. Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Peterson GG; Pu J; Magid DJ; Barterian L; Kranker K; Barna M; Conwell L; Rose A; Blue L; Markovitz A; McCall N; Markovich P
JAMA Cardiol; 2021 Sep; 6(9):1050-1059. PubMed ID: 34076665
[TBL] [Abstract][Full Text] [Related]
77. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
Morales A
BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
[TBL] [Abstract][Full Text] [Related]
78. Recognizing the True Value of Testosterone Therapy in Health Care.
Morgentaler A; Traish A; Barua RS; Dandona P; Dhindsa S; Khera M; Saad F
Androg Clin Res Ther; 2022; 3(1):217-223. PubMed ID: 36643964
[TBL] [Abstract][Full Text] [Related]
79. Statins and prostate cancer prevention: where we are now, and future directions.
Murtola TJ; Visakorpi T; Lahtela J; Syvälä H; Tammela TLj
Nat Clin Pract Urol; 2008 Jul; 5(7):376-87. PubMed ID: 18542103
[TBL] [Abstract][Full Text] [Related]
80. Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.
Zhou Z; Ofori-Asenso R; Curtis AJ; Breslin M; Wolfe R; McNeil JJ; Murray AM; Ernst ME; Reid CM; Lockery JE; Woods RL; Tonkin AM; Nelson MR
J Am Coll Cardiol; 2020 Jul; 76(1):17-27. PubMed ID: 32616158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
